Pricing

CASI PHARMACEUTICALS INC (CASI)

followers ยท
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO: Wei-Wu He
Employees: 180
Web site: casipharmaceuticals.com
9620 MEDICAL CENTER DR, STE 300, ROCKVILLE, MD, 20850
240-864-2600
    Formally known as:
  • EntreMed Inc

Are you looking for this stock instead?

Stock Split History
Date Ratio
2010-07-01 1:11
2022-06-02 1:10
All 13F Filers Prior Change Hedge Funds 1 Prior Change
CASI Pharmaceuticals, Inc. develops and commercializes therapeutics and pharmaceutical products. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-NHL)
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available